256 related articles for article (PubMed ID: 11793375)
1. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study.
Canfield AE; Farrington C; Dziobon MD; Boot-Handford RP; Heagerty AM; Kumar SN; Roberts IS
J Pathol; 2002 Feb; 196(2):228-34. PubMed ID: 11793375
[TBL] [Abstract][Full Text] [Related]
2. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.
Schurgers LJ; Teunissen KJ; Knapen MH; Kwaijtaal M; van Diest R; Appels A; Reutelingsperger CP; Cleutjens JP; Vermeer C
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1629-33. PubMed ID: 15961706
[TBL] [Abstract][Full Text] [Related]
3. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.
Shanahan CM; Cary NR; Metcalfe JC; Weissberg PL
J Clin Invest; 1994 Jun; 93(6):2393-402. PubMed ID: 8200973
[TBL] [Abstract][Full Text] [Related]
4. T-138C polymorphism of matrix gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification.
Kobayashi N; Kitazawa R; Maeda S; Schurgers L; Kitazawa S
Kobe J Med Sci; 2004; 50(3-4):69-81. PubMed ID: 15864013
[TBL] [Abstract][Full Text] [Related]
5. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall.
Spronk HM; Soute BA; Schurgers LJ; Cleutjens JP; Thijssen HH; De Mey JG; Vermeer C
Biochem Biophys Res Commun; 2001 Nov; 289(2):485-90. PubMed ID: 11716499
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix Gla protein and osteonectin mRNA by human aortic smooth muscle cells.
Hao H; Hirota S; Ishibashi-Ueda H; Kushiro T; Kanmatsuse K; Yutani C
Cardiovasc Pathol; 2004; 13(4):195-202. PubMed ID: 15210134
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification.
Sato Y; Nakamura R; Satoh M; Fujishita K; Mori S; Ishida S; Yamaguchi T; Inoue K; Nagao T; Ohno Y
Circ Res; 2005 Sep; 97(6):550-7. PubMed ID: 16100044
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice.
Kaartinen MT; Murshed M; Karsenty G; McKee MD
J Histochem Cytochem; 2007 Apr; 55(4):375-86. PubMed ID: 17189522
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci.
Hirota S; Ito A; Nagoshi J; Takeda M; Kurata A; Takatsuka Y; Kohri K; Nomura S; Kitamura Y
Lab Invest; 1995 Jan; 72(1):64-9. PubMed ID: 7837792
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.
Hirota S; Imakita M; Kohri K; Ito A; Morii E; Adachi S; Kim HM; Kitamura Y; Yutani C; Nomura S
Am J Pathol; 1993 Oct; 143(4):1003-8. PubMed ID: 8213995
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein.
Luo G; Ducy P; McKee MD; Pinero GJ; Loyer E; Behringer RR; Karsenty G
Nature; 1997 Mar; 386(6620):78-81. PubMed ID: 9052783
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors of atherosclerosis in end-stage renal disease patients].
Jono S
Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
[TBL] [Abstract][Full Text] [Related]
13. Osteogenic regulation of vascular calcification: an early perspective.
Vattikuti R; Towler DA
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E686-96. PubMed ID: 15102615
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.
Speer MY; McKee MD; Guldberg RE; Liaw L; Yang HY; Tung E; Karsenty G; Giachelli CM
J Exp Med; 2002 Oct; 196(8):1047-55. PubMed ID: 12391016
[TBL] [Abstract][Full Text] [Related]
15. Relationship between immunological rejection and matrix GLA protein in cryopreserved vascular allografts.
Kiji T; Dohi Y; Nishizaki K; Sakaguchi H; Nagasaka S; Hayata Y; Yonemasu K; Taniguchi S
Transplant Proc; 2004 Oct; 36(8):2415-7. PubMed ID: 15561265
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of arterial calcification.
Schinke T; McKee MD; Kiviranta R; Karsenty G
Ann Med; 1998 Dec; 30(6):538-41. PubMed ID: 9920355
[TBL] [Abstract][Full Text] [Related]
17. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein.
El-Maadawy S; Kaartinen MT; Schinke T; Murshed M; Karsenty G; McKee MD
Connect Tissue Res; 2003; 44 Suppl 1():272-8. PubMed ID: 12952208
[TBL] [Abstract][Full Text] [Related]
18. Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions.
Fischer JW; Steitz SA; Johnson PY; Burke A; Kolodgie F; Virmani R; Giachelli C; Wight TN
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2391-6. PubMed ID: 15472131
[TBL] [Abstract][Full Text] [Related]
19. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.
Cranenburg EC; Vermeer C; Koos R; Boumans ML; Hackeng TM; Bouwman FG; Kwaijtaal M; Brandenburg VM; Ketteler M; Schurgers LJ
J Vasc Res; 2008; 45(5):427-36. PubMed ID: 18401181
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis.
Griethe W; Schmitt R; Jurgensen JS; Bachmann S; Eckardt KU; Schindler R
J Nephrol; 2003; 16(5):728-32. PubMed ID: 14733421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
